Two Sigma Securities’s Aspire Biopharma ASBP Stock Holding History

Two Sigma Securities’s Portfolio ASBP Stock Details ASBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-23	Closed	-$16K	–	2230
2025 Q1	$16K	Buy	+23	New	+$159K	﹤0.01%	1142

Other funds holding ASBP

Procyon Advisors Shelton, Connecticut $2.32B AUM 26.81% 1-Year Est. Return

Crewe Advisors Salt Lake City, Utah $1.38B AUM 41.76% 1-Year Est. Return

Optivise Advisory Services Franklin, Tennessee $197M AUM 26.07% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

VR Advisory Services Camana Bay, Grand Cayman, Cayman Islands $845M AUM 22.79% 1-Year Est. Return

Three Seasons Wealth Salt Lake City, Utah $262M AUM 45.03% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return

Valley Wealth Managers Paramus, New Jersey $1.55B AUM 28.47% 1-Year Est. Return

Platform Technology Partners New York $611M AUM 25.5% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Two Sigma Securities's ASBP Position: Q2 2025 in Review

Two Sigma Securities sold out of Aspire Biopharma (ASBP) in Q2 2025, closing a stake of 23 shares — an estimated $16K sold.

Two Sigma Securities first reported a position in ASBP in Q1 2025 and held it in 1 quarter. The position peaked at $16K in Q1 2025. 14 funds tracked by Wall St. Rank hold ASBP as of Q2 2025.

Two Sigma Securities reported no remaining Aspire Biopharma position as of Q2 2025 after selling out during the quarter.
Two Sigma Securities sold 23 Aspire Biopharma shares in Q2 2025, an estimated $16K.
Two Sigma Securities first reported a position in Aspire Biopharma in Q1 2025 and held it in 1 quarter.
Two Sigma Securities's Aspire Biopharma position peaked at $16K in Q1 2025.
14 funds tracked by Wall St. Rank held Aspire Biopharma as of Q2 2025.

Based on Two Sigma Securities's 13F filing for Q2 2025, filed 14 Aug 2025.